sec.157Selling S4 diversion-risk medicine

sec.157 Selling S4 diversion-risk medicine

This section applies in relation to an S4 medicine that is a diversion-risk medicine for a patient. A pharmacist must not sell the medicine unless the pharmacist reasonably believes— the medicine has been previously prescribed to the patient; and failure to sell the medicine could be life-threatening for the patient; and it is not practicable for the patient to obtain a prescription for the medicine before needing to continue treatment with the medicine. A pharmacist must not sell an amount of the medicine that is— if the medicine is pre-packed—more than the smallest available size of a manufacturer’s pack of the medicine; or otherwise—more than 3 days’ supply of the medicine. s 157 amd 2025 SL No. 60 s 10 (sec.157-ssec.1) This section applies in relation to an S4 medicine that is a diversion-risk medicine for a patient. (sec.157-ssec.2) A pharmacist must not sell the medicine unless the pharmacist reasonably believes— the medicine has been previously prescribed to the patient; and failure to sell the medicine could be life-threatening for the patient; and it is not practicable for the patient to obtain a prescription for the medicine before needing to continue treatment with the medicine. (sec.157-ssec.3) A pharmacist must not sell an amount of the medicine that is— if the medicine is pre-packed—more than the smallest available size of a manufacturer’s pack of the medicine; or otherwise—more than 3 days’ supply of the medicine.

• (a) the medicine has been previously prescribed to the patient; and
• (b) failure to sell the medicine could be life-threatening for the patient; and
• (c) it is not practicable for the patient to obtain a prescription for the medicine before needing to continue treatment with the medicine.
• (a) if the medicine is pre-packed—more than the smallest available size of a manufacturer’s pack of the medicine; or
• (b) otherwise—more than 3 days’ supply of the medicine.